These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19811235)

  • 41. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].
    Simoncini T; Mannella P; Genazzani AR
    Recenti Prog Med; 2003 Feb; 94(2):51-6. PubMed ID: 12908369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogen receptor deficiency leads to impaired endothelial nitric oxide production and premature coronary arteriosclerosis.
    Rubanyi GM
    Ann N Y Acad Sci; 2000 May; 902():302-6. PubMed ID: 10865852
    [No Abstract]   [Full Text] [Related]  

  • 43. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.
    Saitta A; Altavilla D; Cucinotta D; Morabito N; Frisina N; Corrado F; D'Anna R; Lasco A; Squadrito G; Gaudio A; Cancellieri F; Arcoraci V; Squadrito F
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1512-9. PubMed ID: 11557681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vasomotor and vascular effects of hormone replacement therapy.
    Ganz P
    Am J Cardiol; 2002 Jul; 90(1A):11F-16F. PubMed ID: 12106634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection.
    Mijatovic V; van der Mooren MJ; Stehouwer CD; Netelenbos JC; Kenemans P
    Gynecol Endocrinol; 1999 Apr; 13(2):130-44. PubMed ID: 10399059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Vascular protection with estrogen. In-vitro and in-vivo effects--mechanisms and clinical implication].
    Barton M; Wright E; Dai-Do D; Yang Z; Espinosa E; Arnet U; Lüscher TF
    Praxis (Bern 1994); 1997 Jan; 86(5):129-37. PubMed ID: 9064730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oestrogen and the cardiovascular system.
    Teede HJ; McGrath BP;
    Clin Sci (Lond); 2003 Jul; 105(1):9-10. PubMed ID: 12683948
    [No Abstract]   [Full Text] [Related]  

  • 48. The role of estrogen and estrogen-related drugs in cardiovascular diseases.
    Ogita H; Node K; Kitakaze M
    Curr Drug Metab; 2003 Dec; 4(6):497-504. PubMed ID: 14683477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia.
    Stefano GB; Prevot V; Beauvillain JC; Cadet P; Fimiani C; Welters I; Fricchione GL; Breton C; Lassalle P; Salzet M; Bilfinger TV
    Circulation; 2000 Apr; 101(13):1594-7. PubMed ID: 10747354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reproductive hormones and cardiovascular disease mechanism of action and clinical implications.
    Wagner JD; Kaplan JR; Burkman RT
    Obstet Gynecol Clin North Am; 2002 Sep; 29(3):475-93. PubMed ID: 12353669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The vascular protective effects of estrogen.
    Farhat MY; Lavigne MC; Ramwell PW
    FASEB J; 1996 Apr; 10(5):615-24. PubMed ID: 8621060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeted basic research to highlight the role of estrogen and estrogen receptors in the cardiovascular system.
    Dworatzek E; Mahmoodzadeh S
    Pharmacol Res; 2017 May; 119():27-35. PubMed ID: 28119050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Impact of hormone replacement therapy on the cardiovascular system].
    Shviro I; Leitersdorf E
    Harefuah; 1995 May; 128(9):561-6. PubMed ID: 7797159
    [No Abstract]   [Full Text] [Related]  

  • 54. Estrogen and vascular system: more questions for the future.
    Jovanović A; Jovanović S
    Cardiovasc Res; 1999 Apr; 42(1):9-11. PubMed ID: 10434990
    [No Abstract]   [Full Text] [Related]  

  • 55. Postmenopausal hormone replacement therapy and the vascular wall: epidemiology and clinical studies.
    Joswig M; Hach-Wunderle V; von Holst T; Nawroth PP
    Vasa; 2000 Nov; 29(4):243-51. PubMed ID: 11141646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure-function relationship of estrogen receptors in cardiovascular pathophysiological models.
    Arnal JF; Valéra MC; Payrastre B; Lenfant F; Gourdy P
    Thromb Res; 2012 Oct; 130 Suppl 1():S7-11. PubMed ID: 23026669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential estrogen signaling in endothelial cells upon pulsed or continuous administration.
    Simoncini T; Fornari L; Mannella P; Varone G; Caruso A; Garibaldi S; Genazzani AR
    Maturitas; 2005 Apr; 50(4):247-58. PubMed ID: 15780523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular actions of insulin.
    Muniyappa R; Montagnani M; Koh KK; Quon MJ
    Endocr Rev; 2007 Aug; 28(5):463-91. PubMed ID: 17525361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HRT to prevent cardiovascular disease. What studies show, how to advise patients.
    Wood MJ; Cox JL
    Postgrad Med; 2000 Sep; 108(3):59-60, 63-6, 69-72. PubMed ID: 11004936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular system and estrogen in menopause.
    Carbonel AAF; Simões RS; Girão MJBC; Soares Júnior JM; Baracat EC
    Rev Assoc Med Bras (1992); 2020 May; 66(2):97-98. PubMed ID: 32428138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.